Literature DB >> 29359664

Hypoperfusion of the Aortic Wall Secondary to Degeneration of Adventitial Vasa Vasorum Causes Abdominal Aortic Aneurysms.

Hiroki Tanaka1, Naoki Unno2,3, Yuko Suzuki1, Hideto Sano1, Tatsuro Yata2, Tetsumei Urano1.   

Abstract

BACKGROUND: An abdominal aortic aneurysm (AAA), which affects approximately 10% of Japanese men aged ≥ 65 years, is frequently associated with hypertension, dyslipidemia, and other lifestyle- related diseases. The development of an AAA is attributed to chronic inflammation concomitant with arteriosclerotic changes. However, an accurate pathomechanism associated with AAA remains uncertain, and questions such as why only a particular group/percentage of patients with arteriosclerosis develop aneurysms and how diabetes suppresses aneurysm development remain unanswered.
OBJECTIVE: We examined a novel mechanism to develop AAA based on histopathological findings following analysis of the human AAA tissues. Additionally, based on these findings, we developed a new animal model of AAA, in which the histopathological characteristics are similar to human AAA tissue.
RESULTS: Recently, we identified stenosis of the vasa vasorum (VV) in aortic segments showing dilatation. The aorta is the largest artery in our circulatory system. Under physiological conditions, the inner layer of the aorta is nourished via direct diffusion of nutrients from the luminal blood flow, whereas the outer adventitia is primarily perfused by the VV. Therefore, hypoperfusion of the VV induces hypoxia and subsequent inflammation and tissue degeneration of the aortic wall, resulting in aneurysm formation. Based on these findings, we established an AAA animal model by reducing the blood flow through the VV to the aortic wall. AAA was successfully reproduced in our animal model. Histopathological findings in this model were indistinguishable from those observed in humans, and pronounced abnormality in lipid composition in blood vessel adventitia was also observed.
CONCLUSION: Thus, hypoperfusion of the aortic wall appeared to be sufficient to cause inflammationinduced AAA. These findings may provide potential targets for novel therapeutics for the management of an AAA. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Hypoperfusion; abdominal aortic aneurysm; adventitial vasa vasorum; inflammation; novelzzm321990therapeutics; tissue degeneration.

Mesh:

Year:  2018        PMID: 29359664     DOI: 10.2174/1389450119666180122154409

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  4 in total

1.  K-134, a phosphodiesterase 3 inhibitor, reduces vascular inflammation and hypoxia, and prevents rupture of experimental abdominal aortic aneurysms.

Authors:  Naoki Unno; Hiroki Tanaka; Tatsuro Yata; Takafumi Kayama; Yuta Yamanaka; Hajime Tsuyuki; Masaki Sano; Kazunori Inuzuka; Ena Naruse; Hiroya Takeuchi
Journal:  JVS Vasc Sci       Date:  2020-10-22

2.  Toward a unified pathophysiology in COVID-19 acute aortopathies.

Authors:  Luca Roncati; Antonio Manenti; Alberto Farinetti; Gianrocco Manco; Anna Vittoria Mattioli
Journal:  J Vasc Surg       Date:  2021-11       Impact factor: 4.268

Review 3.  Synthesis of multidimensional pathophysiological process leading to type A aortic dissection: a narrative review.

Authors:  Mikko Uimonen
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

4.  Fibrinolysis-resistant carbonylated fibrin detected in thrombi attached to the vascular wall of abdominal aortic aneurysms.

Authors:  Yuko Suzuki; Hiroki Tanaka; Takahiro Horinouchi; Hideto Sano; Naoki Honkura; Naoki Unno; Soichi Miwa; Tetsumei Urano
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.